|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155.00 SEK | +1.51% |
|
+2.79% | -2.58% |
Business description: AddLife AB
Number of employees: 2,327
Sales by Activity: AddLife AB
| Fiscal Period: December | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) |
|---|---|---|---|---|---|
Medtech | 206.16Cr | 362.5Cr | 521Cr | 604.2Cr | 649.6Cr |
Labtech | 321.17Cr | 437.3Cr | 388Cr | 365.4Cr | 379.7Cr |
Group Items | - | -54L | -60L | -1.1Cr | -70L |
Geographical breakdown of sales: AddLife AB
| Fiscal Period: December | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) |
|---|---|---|---|---|---|
Other Countries | 184.18Cr | 297.48Cr | 261.6Cr | 180.6Cr | 188Cr |
UK | - | - | 98Cr | 118.6Cr | 132.9Cr |
Ireland | - | 58Cr | 89Cr | 111.4Cr | 127.4Cr |
Sweden | 107.66Cr | 114.07Cr | 110Cr | 110Cr | 109.7Cr |
Spain | - | - | 72Cr | 83Cr | 98Cr |
Norway | 83Cr | 100.85Cr | 88Cr | 78Cr | 84Cr |
Denmark | 82Cr | 115.81Cr | 96Cr | 79Cr | 76Cr |
Italy | - | - | - | 66Cr | 68Cr |
Finland | 70Cr | 65Cr | 58Cr | 58Cr | 56Cr |
Germany | - | 48Cr | 36Cr | 39Cr | 47Cr |
Switzerland | - | - | - | 45Cr | 41Cr |
Executive Committee: AddLife AB
| Manager | Title | Age | Since |
|---|---|---|---|
Fredrik Dalborg
CEO | Chief Executive Officer | 54 | 01/01/2022 |
| Director of Finance/CFO | - | 01/01/2022 | |
| Chief Tech/Sci/R&D Officer | 57 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Corporate Officer/Principal | 66 | 01/01/2017 |
Composition of the Board of Directors: AddLife AB
| Director | Title | Age | Since |
|---|---|---|---|
Johan Olov Sjö
CHM | Chairman | 59 | 05/03/2015 |
| Director/Board Member | 71 | 01/01/2015 | |
Stefan Hedelius
BRD | Director/Board Member | 57 | 01/01/2015 |
| Director/Board Member | 77 | 01/01/2015 | |
Eva Nilsagård
BRD | Director/Board Member | 62 | 01/01/2015 |
| Director/Board Member | 66 | 01/01/2021 |
Company details: AddLife AB
Group companies: AddLife AB
| Name | Category and Sector |
|---|---|
BioNordika (Sweden) AB
 BioNordika (Sweden) AB Distributes diagnostic and medical products | |
Bergman Diagnostika AS
 Bergman Diagnostika AS Medical SpecialtiesHealth Technology Manufactures and distributes diagnostics and analysis equipment |
Medical Specialties
|
Triolab AB
 Triolab AB Medical/Nursing ServicesHealth Services Provides diagnostics services |
Medical/Nursing Services
|
Biolin Scientific AB
 Biolin Scientific AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells analytical instruments |
Medical Specialties
|
BioNordika Oy
 BioNordika Oy Part of AddLife AB, BioNordika Oy is a company based in Helsinki, Finland. |
Other Medical Equipment, Supplies & Distribution
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.51% | +2.79% | +15.24% | +41.04% | 202Cr | |
| +0.56% | -2.18% | +10.43% | +10.12% | 22TCr | |
| +2.41% | -1.57% | +20.72% | +22.52% | 12TCr | |
| +1.17% | +1.09% | +48.22% | +113.01% | 6.71TCr | |
| +2.93% | +1.00% | -12.18% | -18.93% | 5.74TCr | |
| +4.93% | +7.07% | +27.36% | +96.63% | 5.26TCr | |
| +1.31% | +9.15% | - | - | 3.57TCr | |
| -0.78% | -0.27% | -12.70% | -35.74% | 2.74TCr | |
| +1.69% | +1.62% | +27.43% | +30.80% | 2.55TCr | |
| -2.33% | -5.11% | +2.89% | -34.22% | 2.43TCr | |
| Average | +1.03% | +0.01% | +14.16% | +25.02% | 6.32TCr | |
| Weighted average by Cap. | +0.89% | -1.35% | +15.51% | +26.19% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALIF B Stock
- Company AddLife AB
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition